Skip to main content

A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients

Abstract

Our objective was to model the cost-effectiveness and economic value of routine peri-operative Staphylococcus aureus screening and decolonization of lung and heart-lung transplant recipients from hospital and third-party payer perspectives. We used clinical data from 596 lung and heart-lung transplant recipients to develop a model in TreeAge Pro 2009 (Williamsport, MA, USA). Sensitivity analyses varied S. aureus colonization rate (5–15 %), probability of infection if colonized (10–30 %), and decolonization efficacy (25–90 %). Data were collected from the Cardiothoracic Transplant Program at the University of Pittsburgh Medical Center. Consecutive lung and heart-lung transplant recipients from January 2006 to December 2010 were enrolled retrospectively. Baseline rates of S. aureus colonization, infection and decolonization efficacy were 9.6 %, 36.7 %, and 31.9 %, respectively. Screening and decolonization was economically dominant for all scenarios tested, providing more cost savings and health benefits than no screening. Savings per case averted (2012 $US) ranged from $73,567 to $133,157 (hospital perspective) and $10,748 to $16,723 (third party payer perspective), varying with the probability of colonization, infection, and decolonization efficacy. Using our clinical data, screening and decolonization led to cost savings per case averted of $240,602 (hospital perspective) and averted 6.7 S. aureus infections (4.3 MRSA and 2.4 MSSA); 89 patients needed to be screened to prevent one S. aureus infection. Our data support routine S. aureus screening and decolonization of lung and heart-lung transplant patients. The economic value of screening and decolonization was greater than in previous models of other surgical populations.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Shields RK, Clancy CJ, Minces LR, Kwak EJ, Silveira FP, Abdel-Massih RC, Toyoda Y, Bermudez C, Bhama JK, Shigemura N, Pilewski JM, Crespo MM, Nguyen MH (2012) Staphylococcus aureus infections in the early period after lung transplantation: Epidemiology, risk factors and outcomes. J Heart Lung Transplant 31(7):700–707

    Article  Google Scholar 

  2. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC (2010) Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362(1):9–17

    CAS  PubMed  Google Scholar 

  3. van Rijen M, Bonten M, Wenzel R, Kluytmans J (2008) Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev (4):CD006216

  4. Wenzel RP (2010) Minimizing surgical-site infections. N Engl J Med 362(1):75–77

    CAS  PubMed  Google Scholar 

  5. Edmond MB, Wenzel RP (2013) Screening inpatients for MRSA–case closed. N Engl J Med 368(24):2314–2315

    CAS  PubMed  Article  Google Scholar 

  6. Farr BM (2006) What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am 27(10):1096–1106

    Article  Google Scholar 

  7. Lee BY, Song Y, McGlone SM, Bailey RR, Feura J, Tai JHY, Lewis GJ, Wiringa AE, Smith KJ, Muder RR, Harrison LH, Piraino B (2011) The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA. Clin Microbiol Infect 17(11):1717–1726

    Google Scholar 

  8. Lee BY, Tsui BY, Bailey RR, Smith KJ, Muder RR, Lewis GJ, Harrison LH (2009) Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am 30(12):1158–1165

    Article  Google Scholar 

  9. Lee BY, Wiringa AE, Bailey RR, Goyal V, Lewis GJ, Tsui BY, Smith KJ, Muder RR (2010) Screening cardiac surgery patients for MRSA: an economic computer model. Am J Managed Care 16(7):e163–e173

    Google Scholar 

  10. Lee BY, Wiringa AE, Bailey RR, Goyal V, Tsui B, Lewis GJ, Muder RR, Harrison LH (2010) The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am 31(11):1130–1138

    Article  Google Scholar 

  11. Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R, Ison M, Humar A, Padera RF, Lawler LP, Fisher A, Drew RJ, Gould KF, Sole A, Studer S, Munoz P, Singer LG, Hannan M, Definitions IIDCWGo (2011) A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant: Off Publ Int Soc Heart Transplant 30(4):361–374

    Article  Google Scholar 

  12. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI (2007) Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant: Off Publ Int Soc Heart Transplant 26(8):782–795

    Article  Google Scholar 

  13. Graves N (2004) Economics and preventing hospital-acquired infection. Emerg Infect Dis 10(4):561–566

    PubMed Central  PubMed  Article  Google Scholar 

  14. Vadnerkar A, Toyoda Y, Crespo M, Pilewski J, Mitsani D, Kwak EJ, Silveira FP, Bhama J, Shields R, Bermudez C, Clancy CJ, Nguyen MH (2011) Age-specific complications among lung transplant recipients 60 years and older. J Heart Lung Transplant: Off Publ Int Soc Heart Transplant 30(3):273–281

    Article  Google Scholar 

  15. Lee BY (2008) Digital decision making: computer models and antibiotic prescribing in the twenty-first century. Clin Infect Dis: Off Publ Infect Dis Soc Am 46(8):1139–1141

    Article  Google Scholar 

  16. Puzniak LA, Gillespie KN, Leet T, Kollef M, Mundy LM (2004) A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price? Infect Control Hosp Epidemiol 25:418–424

    PubMed  Article  Google Scholar 

  17. Centers for Medicare and Medicaid Services (2010) 2010 Clinical Diagnostic Laboratory Fee Schedule (CLAB). U.S. Department of Health & Human Services, Baltimore, MD, http://www.cms.gov/ClinicalLabFeeSched/. Cited 27 April 2010

  18. Physicians Desk Reference (2010) Red Book Pharmacy’s Fundamental Reference. Thompson Reuters (Healthcare), Inc, Montvale

    Google Scholar 

  19. American Medical Association (2011) CPT Code/Relative Value Search, https://ocm.ama-assn.org/OCM/CPTRelativeValueSearch.do. Cited 27 April 2011

  20. Bureau of Labor Statistics (2011) Occupational employment statistics: May 2010 national occupational employment and wage estimates, United States. U.S. Bureau of Labor Statistics Division of Occupational Employment Statistics, Washington, D.C., Cited 20 September 2011

    Google Scholar 

  21. AHRQ (2009) United States Department of Health and Human Services HCUP facts and figures: statistics on hospital-based care in the United States, 2009. AHRQ: Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports.jsp. Cited 11 July 2012

  22. Cooke CR, Kahn JM, Watkins TR, Hudson LD, Rubenfeld GD (2009) Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury. Chest 136:79–88

    PubMed Central  PubMed  Article  Google Scholar 

  23. Gold MR, Franks P, McCoy KI, Fryback DG (1998) Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 36(6):778–792

    CAS  PubMed  Article  Google Scholar 

  24. Tengs TO, Wallace A (2000) One thousand health-related quality-of-life estimates. Med Care 38(6):583–637

    CAS  PubMed  Article  Google Scholar 

  25. van Enckevort PJ, TenVergert EM, Bonsel GJ, Geertsma A, van der Bij W, de Boer WJ, Koopmanschap MA, Al MJ, Rutten FF (1998) Technology assessment of the Dutch Lung Transplantation Program. Int J Technol Assess Health Care 14(2):344–356

    PubMed  Article  Google Scholar 

  26. Al MJ, Koopmanschap MA, van Enckevort PJ, Geertsma A, van der Bij W, de Boer WJ, TenVergert EM (1998) Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. Chest 113(1):124–130

    CAS  PubMed  Article  Google Scholar 

  27. Groen H, van der Bij W, Koeter GH, TenVergert EM (2004) Cost-effectiveness of lung transplantation in relation to type of end-stage pulmonary disease. Am J Transplant 4(7):1155–1162

    CAS  PubMed  Article  Google Scholar 

  28. Blumberg EA, Hauser IA, Stanisic S, Mueller E, Berenson K, Gahlemann CG, Humar A, Jardine AG (2010) Prolonged prophylaxis with valganciclovir is cost effective in reducing posttransplant cytomegalovirus disease within the United States. Transplantation 90(12):1420–1426

    CAS  PubMed  Article  Google Scholar 

  29. Morton RL, Howard K, Webster AC, Wong G, Craig JC (2009) The cost-effectiveness of induction immunosuppression in kidney transplantation. Nephrol Dial Transplant 24(7):2258–2269

    PubMed  Article  Google Scholar 

  30. Gordois A, Nobes M, Toohey M, Russ G (2006) Cost-effectiveness of sirolimus therapy with early cyclosporin withdrawal vs. long-term cyclosporin therapy in Australia. Clin Transplant 20(4):526–536

    PubMed  Article  Google Scholar 

  31. Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA (2005) Pertussis in adolescents and adults: should we vaccinate? Pediatrics 115(6):1675–1684

    PubMed  Article  Google Scholar 

  32. Sackett DL, Torrance GW (1978) The utility of different health states as perceived by the general public. J Chron Dis 31(11):697–704

    CAS  PubMed  Article  Google Scholar 

  33. Sakai M, Shimbo T, Omata K, Takahashi Y, Satomura K, Kitamura T, Kawamura T, Baba H, Yoshihara M, Itoh H (2008) Cost-effectiveness of gargling for the prevention of upper respiratory tract infections. BMC Health Serv Res 8:258

    PubMed Central  PubMed  Article  Google Scholar 

  34. Torrance G, Walker V, Grossman R, Mukherjee J, Vaughan D, La Forge J, Lampron N (1999) Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year. Pharmacoeconomics 16(5 Pt 1):499–520

    CAS  PubMed  Article  Google Scholar 

  35. Grossman R, Mukherjee J, Vaughan D, Eastwood C, Cook R, LaForge J, Lampron N (1998) A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group. Chest 113(1):131–141

    CAS  PubMed  Article  Google Scholar 

  36. Selai C, Rosser R (1995) Eliciting EuroQol descriptive data and utility scale values from inpatients. A feasibility study. Pharmacoeconomics 8(2):147–158

    CAS  PubMed  Article  Google Scholar 

  37. Pearson AM, Tosteson AN, Koval KJ, McKee MD, Cantu RV, Bell JE, Vicente M (2010) Is surgery for displaced, midshaft clavicle fractures in adults cost-effective? Results based on a multicenter randomized, controlled trial. J Orthop Trauma 24(7):426–433

    PubMed  Article  Google Scholar 

  38. Grau S, Alvarez-Lerma F, del Castillo A, Neipp R, Rubio-Terres C (2005) Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain. J Chemother 17(2):203–211

    CAS  PubMed  Article  Google Scholar 

  39. Brasel KJ, Borgstrom DC, Weigelt JA (1997) Cost-utility analysis of contaminated appendectomy wounds. J Am Coll Surg 184(1):23–30

    CAS  PubMed  Google Scholar 

  40. Chung KC, Walters MR, Greenfield ML, Chernew ME (1998) Endoscopic versus open carpal tunnel release: a cost-effectiveness analysis. Plast Reconstr Surg 102(4):1089–1099

    CAS  PubMed  Article  Google Scholar 

  41. Jernigan JA, Clemence MA, Stott GA, Titus MG, Alexander CH, Palumbo CM, Farr BM (1995) Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 16(12):686–696

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) grant 5U54GM088491-02, the National Institute of Allergy and Infectious Diseases grant 1RC4AI092327-01, and the Pennsylvania Department of Health. The authors have no conflicts of interest or relevant disclosures.

Author information

Affiliations

Authors

Corresponding author

Correspondence to C. J. Clancy.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Clancy, C.J., Bartsch, S.M., Nguyen, M.H. et al. A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients. Eur J Clin Microbiol Infect Dis 33, 1053–1061 (2014). https://doi.org/10.1007/s10096-013-2046-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-013-2046-y

Keywords

  • Colonization Rate
  • Lung Transplant Recipient
  • Peripherally Insert Central Catheter
  • Aureus Infection
  • Hospital Perspective